Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients (GADES)

AstraZeneca

Status: Completed

Conditions: Gastroprotector Therapy; Compliance; Risk Factors

Study type: Observational

Funder types: Industry

Identifiers

NCT00699725

NIS-GES-DUM-2008/2

Details and patient eligibility

About

Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treatment compliance (both NSAID and PPI), to evaluate the relationship between compliance and NSAID-associated GI events

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed consent
• Patients consulting to the specialized care clinics who have been prescribed NSAID and gastroprotection for at least 15 days following standard clinical practice.

Exclusion criteria

• Any gastroprotective treatment prescribed for other condition than NSAID-related gastrointestinal event prevention

Trial design

2,000 participants in 1 patient group

1

Description:

NSAID patients with risk factors treated with gastroprotective drugs